Form D · Hedge Fund

Avoro Life Sciences Offshore Fund Ltd.

New York, NY · CIK 0001498990

Offering snapshot reported May 1, 2026 · SEC filing

Reported sold
$2.18B
Indefinite offering
Investors reported
290
Form D · investor count
Minimum accepted
$1M
Reported outside-investor minimum
First sale
Jul 1, 2010
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.09B$2.18BAug 13, 2010: $6,900,000.00Aug 13, 2010Aug 1, 2011: $14,400,000.00Nov 8, 2012: $16,400,000.00Oct 21, 2013: $21,900,000.00Oct 17, 2014: $65,840,000.00Oct 9, 2015: $178,486,500.00Oct 11, 2016: $249,289,000.00Oct 11, 2017: $360,999,000.00Sep 7, 2018: $642,799,000.00May 22, 2019: $674,899,025.00May 6, 2020: $927,339,025.00May 3, 2021: $1,084,074,025.00May 2, 2022: $1,447,449,025.00May 2, 2023: $1,768,599,025.00May 2, 2024: $1,996,916,290.00May 2, 2025: $2,109,979,075.00May 1, 2026: $2,180,159,075.00May 1, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$2,109,979,075 → $2,180,159,075
  • Reported investors278 → 290

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 1, 2026Amendment$2,180,159,075$70,180,000vs May 2, 2025290SEC filing
May 2, 2025Amendment$2,109,979,075$113,062,785vs May 2, 2024278SEC filing
May 2, 2024Amendment$1,996,916,290$228,317,265vs May 2, 2023259SEC filing
May 2, 2023Amendment$1,768,599,025$321,150,000vs May 2, 2022248SEC filing
May 2, 2022Amendment$1,447,449,025$363,375,000vs May 3, 2021229SEC filing
May 3, 2021Amendment$1,084,074,025$156,735,000vs May 6, 2020185SEC filing
May 6, 2020Amendment$927,339,025$252,440,000vs May 22, 2019160SEC filing
May 22, 2019Amendment$674,899,025$32,100,025vs Sep 7, 2018147SEC filing
Sep 7, 2018Amendment$642,799,000$281,800,000vs Oct 11, 2017146SEC filing
Oct 11, 2017Amendment$360,999,000$111,710,000vs Oct 11, 2016121SEC filing
Oct 11, 2016Amendment$249,289,000$70,802,500vs Oct 9, 201596SEC filing
Oct 9, 2015Amendment$178,486,500$112,646,500vs Oct 17, 201482SEC filing
Oct 17, 2014Amendment$65,840,000$43,940,000vs Oct 21, 201351SEC filing
Oct 21, 2013Amendment$21,900,000$5,500,000vs Nov 8, 20127SEC filing
Nov 8, 2012Amendment$16,400,000$2,000,000vs Aug 1, 20113SEC filing
Aug 1, 2011Amendment$14,400,000$7,500,000vs Aug 13, 20101SEC filing
Aug 13, 2010Initial$6,900,000No comparison2SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
Yes
Business combination
No
Sales commissions
$63.7M (estimated)
Finders' fees
$0 (estimated)
Form D file number
021-146407

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Far Hills Group LLC000032243
Direct Access Partners, LLC000120950

Source: Form D, filed May 1, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

AVORO LIFE SCIENCES OFFSHORE FUND LTD.

Investment adviser: AVORO CAPITAL ADVISORS LLC

Gross asset value
Not reported
Beneficial owners
Not reported
ADV minimum commitment
Not reported

Reported in Form ADV on Mar 5, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

No provider names available in this fund's imported disclosure.

Provider details
Annual audit
Not reported
Prime brokers
Not reported
Custodians
Not reported
Administrator other than the adviser
Not reported
External marketing
Not reported
Filing source

Form ADV 2061300 · Mar 5, 2026 · Schedule D 7.B.(1), fund 805-3986373170

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Robert Adelman Executive
Behzad Aghazadeh Executive
Avoro Capital Advisors Llc Promoter
Avoro Capital Gp, Llc Promoter
Avoro Capital L.P. Promoter
Paul Brooke Executive
Neil Cammarosano Executive
Scott Epstein Executive
Corey Goodman Executive
Llc Ven Bio Select Advisor Promoter
N/A Ven Bio Select Advisor Llc Promoter
N/A Ven Bio Select Advisor L.P. Promoter
N/A Ven Bio Select Advisor Management Holdings Gp, Llc Promoter
Kurt Von Emster Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
110 Greene Street Suite 800
New York, NY, 10012